Thyroid News and Research

RSS

Defining the limits of immunotherapy in early small-cell lung cancer

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, led by NRG Oncology in collaboration with the Alliance for Clinical Trials in Oncology. The results are published in the Journal of Clinical Oncology.

13 Mar 2026

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

A large cohort study of more than 600,000 US veterans with type 2 diabetes found that initiating GLP-1 receptor agonists was associated with lower risks of developing substance use disorders compared with SGLT-2 inhibitors. Among veterans with existing substance use disorders, GLP-1 receptor agonist use was also linked to fewer overdose events, hospitalizations, and suicide-related outcomes.

8 Mar 2026

Virtual immunostaining method improves detection of vascular invasion in thyroid cancer

In a groundbreaking study published in BME Frontiers, researchers from the University of California, Los Angeles (UCLA), in collaboration with international partners, have developed a deep learning-based virtual multiplexed immunostaining (mIHC) method.

6 Mar 2026

COVID vaccination during pregnancy linked to lower preeclampsia risk

A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication.

18 Feb 2026

How GLP-1 drugs affect the body beyond weight loss and glucose control

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.

18 Feb 2026

Vitamin A and thyroid hormones in the retina shape fetal vision

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.

13 Feb 2026

Telehealth boosts uptake of genetic testing among adult survivors of childhood cancers

Adult survivors of childhood cancers are at higher risk for another cancer – such as breast, colorectal, sarcomas and thyroid cancer – that is not a relapse of their original illness.

13 Feb 2026

Engineered liver tissue model mimics early metabolic liver disease

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver.

3 Feb 2026

AI uncovers evolution of genetic control elements in mammalian cerebellum

Artificial intelligence allows tracing the evolution of genetic control elements in the developing mammalian cerebellum.

30 Jan 2026

Turning everyday eggs into powerful nutrient delivery systems

Eggs as functional foods: this review explores enrichment techniques that enhance nutrient bioavailability and support health through precision nutrition.

30 Jan 2026

Is fluoridated water safe during pregnancy? Studies say yes

Research analyzing 11.5 million births finds no association between community water fluoridation and reduced birth weight, ensuring prenatal safety.

23 Jan 2026

Study explores how shared cells influence health across generations

During pregnancy, maternal and fetal cells migrate back and forth across the placenta, with fetal cells entering the mother's bloodstream and tissues.

22 Jan 2026

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), represent the most common chronic liver diseases in Western populations, driven largely by obesity and insulin resistance.

21 Jan 2026

Research suggests bamboo-based foods could support metabolic health

This systematic review synthesizes human, in vitro, and food-processing studies on bamboo consumption, finding limited but suggestive evidence for metabolic, digestive, and antioxidant benefits when products are properly prepared. It also highlights safety considerations, including potential goitrogenic effects from inadequately processed shoots, and calls for higher-quality human trials.

18 Jan 2026